HUP0105477A2 - Metalloproteináz mátrixok reverz hidroxamát inhibitorai és alkalmazásuk gyógyszerkészítmények előállítására - Google Patents

Metalloproteináz mátrixok reverz hidroxamát inhibitorai és alkalmazásuk gyógyszerkészítmények előállítására Download PDF

Info

Publication number
HUP0105477A2
HUP0105477A2 HU0105477A HUP0105477A HUP0105477A2 HU P0105477 A2 HUP0105477 A2 HU P0105477A2 HU 0105477 A HU0105477 A HU 0105477A HU P0105477 A HUP0105477 A HU P0105477A HU P0105477 A2 HUP0105477 A2 HU P0105477A2
Authority
HU
Hungary
Prior art keywords
propionic acid
acetylamino
ylamino
nitrophenyl
methylpyridin
Prior art date
Application number
HU0105477A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael L. Curtin
Yujia Dai
Steven K. Davidsen
Howard R. Heyman
James H. Holmes
Michael R. Michaelides
Douglas H. Steinman
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of HUP0105477A2 publication Critical patent/HUP0105477A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0105477A 1999-01-27 2000-01-27 Metalloproteináz mátrixok reverz hidroxamát inhibitorai és alkalmazásuk gyógyszerkészítmények előállítására HUP0105477A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23908799A 1999-01-27 1999-01-27

Publications (1)

Publication Number Publication Date
HUP0105477A2 true HUP0105477A2 (hu) 2002-05-29

Family

ID=22900549

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105477A HUP0105477A2 (hu) 1999-01-27 2000-01-27 Metalloproteináz mátrixok reverz hidroxamát inhibitorai és alkalmazásuk gyógyszerkészítmények előállítására

Country Status (28)

Country Link
US (1) US20020007060A1 (enExample)
EP (1) EP1147101B1 (enExample)
JP (1) JP4718686B2 (enExample)
KR (1) KR100748010B1 (enExample)
CN (1) CN1222519C (enExample)
AR (1) AR029329A1 (enExample)
AT (1) ATE228122T1 (enExample)
AU (1) AU764383B2 (enExample)
BG (1) BG105782A (enExample)
BR (1) BR0007278A (enExample)
CA (1) CA2358951C (enExample)
CO (1) CO5150194A1 (enExample)
CZ (1) CZ20012591A3 (enExample)
DE (1) DE60000819T2 (enExample)
DK (1) DK1147101T3 (enExample)
ES (1) ES2187443T3 (enExample)
HK (1) HK1043115A1 (enExample)
HU (1) HUP0105477A2 (enExample)
IL (1) IL143713A0 (enExample)
NO (1) NO20013669L (enExample)
NZ (1) NZ512372A (enExample)
PL (1) PL349771A1 (enExample)
PT (1) PT1147101E (enExample)
SK (1) SK10582001A3 (enExample)
TR (1) TR200102159T2 (enExample)
TW (1) TWI225486B (enExample)
WO (1) WO2000044739A1 (enExample)
ZA (1) ZA200104979B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
AU2001298065A1 (en) * 2001-01-12 2003-09-02 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
EP1431285B1 (en) 2001-09-07 2009-01-07 Kaken Pharmaceutical Co., Ltd. Reverse hydroxamic acid derivatives
EP1896404B1 (en) * 2005-06-27 2014-09-17 Nabriva Therapeutics AG Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
WO2015107139A1 (en) 2014-01-17 2015-07-23 Proyecto De Biomedicina Cima, S.L. Compounds for use as antifibrinolytic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0780386B1 (en) * 1995-12-20 2002-10-02 F. Hoffmann-La Roche Ag Matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
CA2358951A1 (en) 2000-08-03
AU2739100A (en) 2000-08-18
HK1043115A1 (zh) 2002-09-06
JP2002535398A (ja) 2002-10-22
IL143713A0 (en) 2002-04-21
TR200102159T2 (tr) 2001-12-21
BG105782A (en) 2002-04-30
US20020007060A1 (en) 2002-01-17
SK10582001A3 (sk) 2001-12-03
AR029329A1 (es) 2003-06-25
NO20013669D0 (no) 2001-07-26
EP1147101A1 (en) 2001-10-24
WO2000044739A1 (en) 2000-08-03
PL349771A1 (en) 2002-09-09
NZ512372A (en) 2003-01-31
TWI225486B (en) 2004-12-21
ATE228122T1 (de) 2002-12-15
CN1339032A (zh) 2002-03-06
BR0007278A (pt) 2001-11-27
ZA200104979B (en) 2002-09-18
NO20013669L (no) 2001-09-27
EP1147101B1 (en) 2002-11-20
DE60000819D1 (de) 2003-01-02
CZ20012591A3 (cs) 2001-12-12
DE60000819T2 (de) 2003-09-04
CO5150194A1 (es) 2002-04-29
PT1147101E (pt) 2003-04-30
DK1147101T3 (da) 2003-03-10
AU764383B2 (en) 2003-08-14
CA2358951C (en) 2009-10-20
KR20010101709A (ko) 2001-11-14
CN1222519C (zh) 2005-10-12
KR100748010B1 (ko) 2007-08-09
ES2187443T3 (es) 2003-06-16
JP4718686B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
US6326403B1 (en) Diacylhydrazine derivatives as integrin inhibitors
HUP0105479A2 (hu) Béta-alanin-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
RU2234505C2 (ru) Производные хроменона и хроманона в качестве ингибиторов интегринов
HUP0303716A2 (hu) Piridin-2-il-amino-alkil-karbonil-glicil-béta-alanin és származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
JP4216071B2 (ja) インテグリン阻害剤としての尿素およびウレタン誘導体
HUP0105477A2 (hu) Metalloproteináz mátrixok reverz hidroxamát inhibitorai és alkalmazásuk gyógyszerkészítmények előállítására
KR20030022418A (ko) 비페닐 유도체, 및 인테그린 저해제로서의 그의 용도
US6649613B1 (en) Diacylhydrazine derivatives
CZ20033000A3 (cs) Inhibitory integrinů a(v)B6
HUP0203212A2 (hu) Integrin inhibitorok, eljárás ezek előállítására, alkalmazásuk gyógyszerkészítmények előállítására és a készítmények
JP2003507458A (ja) 新規なインテグリンαvβ3阻害剤
MXPA01010294A (es) Derivados de dibenzoazuleno para el tratamiento de la trombosis, osteoporosis, arteriosclerosis.
AU6828600A (en) Fluorene derivatives
US20030187289A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
MXPA01008424A (en) &bgr;-ALANINE DERIVATIVES
MXPA98010586A (en) Phenylalanin derivatives as laintegr inhibitors

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees